Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | FPR2 | P25090 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28880300 | 0.91 | TSHR (0.81) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL23400077 | 0.88 | KDM4E (0.63) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL23403469 | 0.88 | TSHR (0.58) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL28880361 | 0.87 | KDM4E (1.00) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL28492314 | 0.86 | TSHR (0.69) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL30410560 | 0.85 | TSHR (0.72) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL28496843 | 0.85 | KDM4E (0.67) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL14428441 | 0.84 | FPR2 (0.88) | TSHRMAPTPOLBKMT2AMEN1 | |
| SCHEMBL28340952 | 0.83 | TSHR (0.82) | TSHRKDM4EMAPTGAALMNA | |
| SCHEMBL8651089 | 0.83 | KDM4E (0.68) | TSHRKDM4EMAPTGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113200916-A | Antipyrine functional monomer, preparation method thereof and organophosphorus pesticide molecularly imprinted polymer prepared based on antipyrine functional monomer | 天津科技大学 | 2021-08-03 | — | — | CN | claimed |
| US-20250376689-A1 | OLIGONUCLEOTIDES HAVING 6-THIO-2'-DEOXYGUANOSINE RESIDUES AND USES THEREOF | HOPE CITY (US) | 2025-12-11 | — | — | US | disclosed |
| CN-118829450-A | Eptification derivative-antibody conjugate and medical application thereof | 甘李药业股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-116672759-A | Neodymium-silicon co-doped TiO 2 Application of nano material, processing method of animal-derived food sample and application of animal-derived food sample | 中国检验认证集团湖南有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-114315723-B | Analgin residual marker hapten and artificial antigen as well as preparation methods and applications thereof | 中国农业大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-116514718-A | Hybridoma cell strain, analgin residue marker 4-methylamino antipyrine monoclonal antibody secreted by hybridoma cell strain and application of analgin residue marker | 河南农业大学 | 2023-08-01 | — | — | CN | disclosed |
| CN-113676903-B | Slice authentication authorization management method, device and system | 华为技术有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-114480382-A | RNAi agents and compositions for inhibiting SURF4 gene expression | 北京大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-114315723-A | Analgin residual marker hapten and artificial antigen as well as preparation methods and application thereof | 中国农业大学 | 2022-04-12 | — | — | CN | disclosed |
| CN-113200916-A | Antipyrine functional monomer, preparation method thereof and organophosphorus pesticide molecularly imprinted polymer prepared based on antipyrine functional monomer | 天津科技大学 | 2021-08-03 | — | — | CN | disclosed |
| US-20020132935-A1 | Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers | PPG INDUSTRIES OHIO, INC. | 2002-09-19 | — | — | US | disclosed |
| US-20020071955-A1 | Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers | PPG INDUSTRIES OHIO, INC. | 2002-06-13 | — | — | US | disclosed |
| US-20020040112-A1 | Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers | PPG INDUSTRIES OHIO, INC. | 2002-04-04 | — | — | US | disclosed |
| US-20020037973-A1 | Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers | PPG INDUSTRIES OHIO, INC. | 2002-03-28 | — | — | US | disclosed |
| EP-1150660-A1 | PHARMACEUTICAL EFFERVESCENT FORMULATION CONTAINING METAMIZOL | HEXAL AG (DE) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000066088-A1 | CONTROLLED RELEASE PHARMACEUTICAL PREPARATION CONTAINING METAMIZOLE | HEXAL AG (DE) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000047189-A1 | PHARMACEUTICAL EFFERVESCENT FORMULATION CONTAINING METAMIZOL | HEXAL AG (DE) | 2000-08-17 | — | — | WO | disclosed |
| US-5760216-A | REACTING DRUG SAMPLE WITH SYNTHETIC METALLOPORPHYRIN, OXIDIZING AGENT, SOLVENT TO FORM OXIDATION PRODUCT | ABBOTT LABORATORIES (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0781261-A2 | USE OF SYNTHETIC METALLOPORPHYRINS FOR PREPARATION AND PREDICTION OF DRUG METABOLITES | Abbott Laboratories (US) | 1997-07-02 | — | — | EP | disclosed |
| WO-1996008455-A2 | USE OF SYNTHETIC METALLOPORPHYRINS FOR PREPARATION AND PREDICTION OF DRUG METABOLITES | ABBOTT LABORATORIES (US) | 1996-03-21 | — | — | WO | disclosed |